Bioconjugated quantum dots for in vivo molecular and cellular imaging

Andrew M. Smith, Hongwei Duan, Aaron M. Mohs, Shuming Nie

Research output: Contribution to journalReview article

876 Citations (Scopus)

Abstract

Semiconductor quantum dots (QDs) are tiny light-emitting particles on the nanometer scale, and are emerging as a new class of fluorescent labels for biology and medicine. In comparison with organic dyes and fluorescent proteins, they have unique optical and electronic properties, with size-tunable light emission, superior signal brightness, resistance to photobleaching, and broad absorption spectra for simultaneous excitation of multiple fluorescence colors. QDs also provide a versatile nanoscale scaffold for designing multifunctional nanoparticles with both imaging and therapeutic functions. When linked with targeting ligands such as antibodies, peptides or small molecules, QDs can be used to target tumor biomarkers as well as tumor vasculatures with high affinity and specificity. Here we discuss the synthesis and development of state-of-the-art QD probes and their use for molecular and cellular imaging. We also examine key issues for in vivo imaging and therapy, such as nanoparticle biodistribution, pharmacokinetics, and toxicology.

Original languageEnglish (US)
Pages (from-to)1226-1240
Number of pages15
JournalAdvanced Drug Delivery Reviews
Volume60
Issue number11
DOIs
StatePublished - Aug 17 2008

Fingerprint

Quantum Dots
Molecular Imaging
Nanoparticles
Photobleaching
Light
Semiconductors
Tumor Biomarkers
Fluorescent Dyes
Toxicology
Pharmacokinetics
Color
Fluorescence
Medicine
Ligands
Peptides
Antibodies
Therapeutics
Neoplasms
Proteins

Keywords

  • Biomarkers
  • Cancer
  • Cellular imaging
  • Drug delivery
  • Fluorescence
  • Molecular imaging
  • Nanocrystals
  • Nanoparticles
  • Nanotechnology
  • Quantum dots
  • Toxicology

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Bioconjugated quantum dots for in vivo molecular and cellular imaging. / Smith, Andrew M.; Duan, Hongwei; Mohs, Aaron M.; Nie, Shuming.

In: Advanced Drug Delivery Reviews, Vol. 60, No. 11, 17.08.2008, p. 1226-1240.

Research output: Contribution to journalReview article

Smith, Andrew M. ; Duan, Hongwei ; Mohs, Aaron M. ; Nie, Shuming. / Bioconjugated quantum dots for in vivo molecular and cellular imaging. In: Advanced Drug Delivery Reviews. 2008 ; Vol. 60, No. 11. pp. 1226-1240.
@article{7c806d8cf12e438fad4d370bbd0e2de1,
title = "Bioconjugated quantum dots for in vivo molecular and cellular imaging",
abstract = "Semiconductor quantum dots (QDs) are tiny light-emitting particles on the nanometer scale, and are emerging as a new class of fluorescent labels for biology and medicine. In comparison with organic dyes and fluorescent proteins, they have unique optical and electronic properties, with size-tunable light emission, superior signal brightness, resistance to photobleaching, and broad absorption spectra for simultaneous excitation of multiple fluorescence colors. QDs also provide a versatile nanoscale scaffold for designing multifunctional nanoparticles with both imaging and therapeutic functions. When linked with targeting ligands such as antibodies, peptides or small molecules, QDs can be used to target tumor biomarkers as well as tumor vasculatures with high affinity and specificity. Here we discuss the synthesis and development of state-of-the-art QD probes and their use for molecular and cellular imaging. We also examine key issues for in vivo imaging and therapy, such as nanoparticle biodistribution, pharmacokinetics, and toxicology.",
keywords = "Biomarkers, Cancer, Cellular imaging, Drug delivery, Fluorescence, Molecular imaging, Nanocrystals, Nanoparticles, Nanotechnology, Quantum dots, Toxicology",
author = "Smith, {Andrew M.} and Hongwei Duan and Mohs, {Aaron M.} and Shuming Nie",
year = "2008",
month = "8",
day = "17",
doi = "10.1016/j.addr.2008.03.015",
language = "English (US)",
volume = "60",
pages = "1226--1240",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - Bioconjugated quantum dots for in vivo molecular and cellular imaging

AU - Smith, Andrew M.

AU - Duan, Hongwei

AU - Mohs, Aaron M.

AU - Nie, Shuming

PY - 2008/8/17

Y1 - 2008/8/17

N2 - Semiconductor quantum dots (QDs) are tiny light-emitting particles on the nanometer scale, and are emerging as a new class of fluorescent labels for biology and medicine. In comparison with organic dyes and fluorescent proteins, they have unique optical and electronic properties, with size-tunable light emission, superior signal brightness, resistance to photobleaching, and broad absorption spectra for simultaneous excitation of multiple fluorescence colors. QDs also provide a versatile nanoscale scaffold for designing multifunctional nanoparticles with both imaging and therapeutic functions. When linked with targeting ligands such as antibodies, peptides or small molecules, QDs can be used to target tumor biomarkers as well as tumor vasculatures with high affinity and specificity. Here we discuss the synthesis and development of state-of-the-art QD probes and their use for molecular and cellular imaging. We also examine key issues for in vivo imaging and therapy, such as nanoparticle biodistribution, pharmacokinetics, and toxicology.

AB - Semiconductor quantum dots (QDs) are tiny light-emitting particles on the nanometer scale, and are emerging as a new class of fluorescent labels for biology and medicine. In comparison with organic dyes and fluorescent proteins, they have unique optical and electronic properties, with size-tunable light emission, superior signal brightness, resistance to photobleaching, and broad absorption spectra for simultaneous excitation of multiple fluorescence colors. QDs also provide a versatile nanoscale scaffold for designing multifunctional nanoparticles with both imaging and therapeutic functions. When linked with targeting ligands such as antibodies, peptides or small molecules, QDs can be used to target tumor biomarkers as well as tumor vasculatures with high affinity and specificity. Here we discuss the synthesis and development of state-of-the-art QD probes and their use for molecular and cellular imaging. We also examine key issues for in vivo imaging and therapy, such as nanoparticle biodistribution, pharmacokinetics, and toxicology.

KW - Biomarkers

KW - Cancer

KW - Cellular imaging

KW - Drug delivery

KW - Fluorescence

KW - Molecular imaging

KW - Nanocrystals

KW - Nanoparticles

KW - Nanotechnology

KW - Quantum dots

KW - Toxicology

UR - http://www.scopus.com/inward/record.url?scp=46749091612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749091612&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2008.03.015

DO - 10.1016/j.addr.2008.03.015

M3 - Review article

C2 - 18495291

AN - SCOPUS:46749091612

VL - 60

SP - 1226

EP - 1240

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 11

ER -